GW427353

GW427353 · GlaxoSmithKline

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GW427353, covering 2009-05-18 to 2009-05-18. Get the full timeline:

Most recent: Clinical Trial Update: A Study To Investigate GW427353 In Subjects With Irritable Bowel Syndrome (IBS) [Phase 2]